Zogenix Inc - ESG Rating & Company Profile powered by AI
This analysis of Zogenix Inc employs intelligence from across the web as well as from public disclosures by Zogenix Inc. Alternative corporations in the rating industry group for Zogenix Inc are displayed below. Detailed Sustainability analysis of Zogenix Inc can be accessed by registering for free.
Zogenix Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.7; made up of an environmental score of 6.0, social score of 6.4 and governance score of 1.6.
4.7
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
816 | Pliant Therapeutics Inc | 4.8 | High |
816 | Voyager Therapeutics Inc | 4.8 | High |
837 | Zogenix Inc | 4.7 | High |
837 | Bio Rad Laboratories Inc | 4.7 | High |
837 | Katakura Industries Co Ltd | 4.7 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Zogenix Inc have an accelerator or VC vehicle to help deliver innovation?
Does Zogenix Inc disclose current and historical energy intensity?
Does Zogenix Inc report the average age of the workforce?
Does Zogenix Inc reference operational or capital allocation in relation to climate change?
Does Zogenix Inc disclose its ethnicity pay gap?
Does Zogenix Inc disclose cybersecurity risks?
Does Zogenix Inc offer flexible work?
Does Zogenix Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Zogenix Inc disclose the number of employees in R&D functions?
Does Zogenix Inc conduct supply chain audits?
Does Zogenix Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Zogenix Inc conduct 360 degree staff reviews?
Does Zogenix Inc disclose the individual responsible for D&I?
Does Zogenix Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Zogenix Inc disclose current and / or historical scope 2 emissions?
Does Zogenix Inc disclose water use targets?
Does Zogenix Inc have careers partnerships with academic institutions?
Did Zogenix Inc have a product recall in the last two years?
Does Zogenix Inc disclose incidents of discrimination?
Does Zogenix Inc allow for Work Councils/Collective Agreements to be formed?
Has Zogenix Inc issued a profit warning in the past 24 months?
Does Zogenix Inc disclose parental leave metrics?
Does Zogenix Inc disclose climate scenario or pathway analysis?
Does Zogenix Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Zogenix Inc disclose the pay ratio of women to men?
Does Zogenix Inc support suppliers with sustainability related research and development?
Does Zogenix Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Zogenix Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Zogenix Inc involved in embryonic stem cell research?
Does Zogenix Inc disclose GHG and Air Emissions intensity?
Does Zogenix Inc disclose its waste policy?
Does Zogenix Inc report according to TCFD requirements?
Does Zogenix Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Zogenix Inc disclose energy use targets?
Does Zogenix Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Zogenix Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Zogenix Inc
These potential risks are based on the size, segment and geographies of the company.
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California.